Observational study on quality of life, safety, and effectiveness of first‐line cetuximab plus chemotherapy in <i><scp>KRAS</scp></i> wild‐type metastatic colorectal cancer patients: the ObservEr StudyCarmine Pinto, Francesco Di Costanzo, Daris Ferrari et al.|Cancer Medicine|2016Cited by 26
Quality of life, compliance, safety and effectiveness in fit older metastatic colorectal patients with cancer treated in first-line with chemotherapy plus cetuximab: A restrospective analysis from the ObservEr studyGerardo Rosati, Francesco Di Costanzo, Carmine Pinto et al.|Journal of Geriatric Oncology|2018Cited by 13
Italian survey on cetuximab-based therapy of elderly patients with metastatic colorectal cancerGerardo Rosati, S. Bianco, Raffaele Addeo et al.|Cancer Chemotherapy and Pharmacology|2019Cited by 4